Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cytosorbents Corp

CTSO ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: HOLD

Last Close

$0.40

▲ +10.38%

Market Cap $25.13M · Vol 3.32K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$25.13M

Micro Cap

Div Yield

N/A

EPS Growth

-61.54%

YoY

RSI (14)

61.32

Momentum

Beta

1.37

vs Market

52W High

$1.16

65.53% below

52W Low

$0.35

14.22% above

Volume

3.32K

Avg 8.19K

P/B

6.80

Price-to-book

ROE

N/A

Return on equity

Free Float

84.28%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Cytosorbents Corp (CTSO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CTSO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+11.08%

+2.93%

-26.19%

-37.65%

YTD

-37.44%

-64.92%

-85.67%

-94.89%

Financials & Valuation

TTM · Annual

Total Revenue	$37.06M
Net Income	$-8,198,000.00
Revenue Growth (YoY)	+0.17%
Gross Margin	71.48%
Operating Margin	-36.80%
Net Profit Margin	-22.12%
ROE	N/A
ROA · ROIC	-18.78% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.07
P/B	6.80
P/FCF	N/A
EPS Growth	-61.54%
Outstanding Shares	62.84M

Technical Indicators

50-Day SMA	$0.40
200-Day SMA	$0.59
RSI (14)	61.32
Beta	1.37
52-Week High	$1.16
52-Week Low	$0.35

Volume Today	3.32K
Avg Daily Volume (30D)	8.19K
Relative Volume	0.40x
Volatility (10D)	75.77
Volatility (30D)	68.88
Free Float	84.28%

Analyst Consensus

HOLD

Current Price $0.40

Mean Target $2.88

52W Low$0.35 52W High$1.16

Current

Target

$0.35 $1.16

Current Analyst target

+618.93% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SL7YQ0

ISINUS23283X2062

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 3, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.